Biomarkers in sepsis
Juhi Saxena,
No information about this author
Sarvjeet Das,
No information about this author
Anshu Kumar
No information about this author
et al.
Clinica Chimica Acta,
Journal Year:
2024,
Volume and Issue:
562, P. 119891 - 119891
Published: July 26, 2024
Language: Английский
The Role of Monocyte Distribution Width (MDW) in the Prediction of Death in Adult Patients with Sepsis
Microorganisms,
Journal Year:
2025,
Volume and Issue:
13(2), P. 427 - 427
Published: Feb. 15, 2025
Sepsis
is
a
life-threatening
condition;
it
major
cause
of
hospital
mortality
worldwide
and
constitutes
global
health
problem.
This
research
investigates
the
use
MDW
as
predictor
for
septic
patients.
was
double-center
prospective
cohort
study
adult
Septic
patients
were
identified
categorized
into
two
categories:
those
who
improved
died.
Blood
drawn
from
three
times,
on
first,
third,
fifth
day
their
admission
to
hospital.
evaluated
biomarker
predict
patient
outcome.
In
addition,
existing
inflammatory
markers
recorded
in
all
The
able
patient's
average
found
be
significantly
higher
died
records.
For
example,
an
value
28.4
first
shown
best
cut-off
determining
fatal
outcomes;
receiver
operating
characteristic
(ROC)
analysis
revealed
area
under
curve
0.71
(95%
Confidence
Interval-CI:
0.57-0.84)
with
sensitivity
64.7%
specificity
88.2%.
conclusion,
MDW,
addition
being
marker
that
can
quickly
detect
sepsis
more
effectively
than
other
biomarkers,
which
proven
by
numerous
studies,
could
also
used
indicator
work
attempt
direction.
Language: Английский
Diagnostic Performance of Monocyte Distribution Width for the Detection of Sepsis: A Systematic Review and Meta-Analysis
Journal of the American College of Emergency Physicians Open,
Journal Year:
2025,
Volume and Issue:
6(2), P. 100073 - 100073
Published: Feb. 21, 2025
To
aggregate
literature
on
the
diagnostic
performance
of
monocyte
distribution
width
(MDW)
for
sepsis
detection
among
adults
in
emergency
department
and
inpatient
settings.
We
searched
MEDLINE,
EMBASE,
SCOPUS,
Cochrane
databases
studies
evaluating
MDW
diagnosis
hospital
setting
through
October
19,
2024.
Two
authors
(G.E.
Q.H.)
independently
performed
eligibility
assessment,
data
extraction,
risk
bias
assessment.
evaluated
sepsis-2
sepsis-3
separately
applied
separate
thresholds
depending
anticoagulant
used
blood
collection.
Data
were
pooled
using
a
random-effects
model.
multiple
sensitivity
analyses
to
evaluate
stability
our
findings.
Twenty-five
observational
comprising
39,041
patients
included.
The
area
under
summary
receiver
operating
curve
(AUC)
was
0.82
(95%
CI,
0.78-0.85)
both
sepsis-3.
Sensitivity
specificity
0.79
0.74-0.83)
0.7
0.61-0.78)
0.83
0.78-0.88)
0.64
0.55-0.71)
threshold-independent
weighted-average
AUC
0.76
(SD,
0.1)
0.77
0.07)
negative
predictive
value
94%
96%
observed
similar
across
all
analyses.
assessed
overall
quality
evidence
be
low.
performs
similarly
other
biomarkers
such
as
procalcitonin
sepsis,
with
unique
advantage
rapid
availability
part
routine
testing.
Language: Английский
The Need for Standardized Guidelines for the Use of Monocyte Distribution Width (MDW) in the Early Diagnosis of Sepsis
Andrea Piccioni,
No information about this author
Fabio Spagnuolo,
No information about this author
Silvia Baroni
No information about this author
et al.
Journal of Personalized Medicine,
Journal Year:
2024,
Volume and Issue:
15(1), P. 5 - 5
Published: Dec. 27, 2024
Sepsis
is
a
complex
and
potentially
life-threatening
syndrome
characterized
by
an
abnormal
immune
response
to
infection,
which
can
lead
organ
dysfunction,
septic
shock,
death.
Early
diagnosis
crucial
improving
prognosis
reducing
hospital
management
costs.
This
narrative
review
aims
summarize
evaluate
the
current
literature
on
role
of
monocyte
distribution
width
(MDW)
as
diagnostic
biomarker
for
sepsis,
highlighting
its
advantages,
limitations,
potential
clinical
applications.
MDW
measures
volumetric
monocytes,
reflecting
monocytic
anisocytosis,
detected
using
advanced
hematological
analyzers.
In
2019,
it
was
approved
FDA
sepsis
due
ability
identify
systemic
inflammatory
at
early
stage.
Thirty-one
studies
analyzed
us
have
shown
that
increased
value
associated
with
higher
risk
combination
parameters
(such
qSOFA)
other
biomarkers
(CRP,
PCT)
enhance
sensitivity
stratification
capacity.
Despite
high
sensitivity,
has
lower
specificity
compared
more
established
such
procalcitonin,
thus
requiring
multimodal
integration
accurate
diagnosis.
The
use
in
emergency
intensive
care
settings
represents
opportunity
improve
critical
patient
management,
particularly
when
combined
markers
tools.
However,
further
are
needed
define
universal
cut-off
confirm
validity
different
contexts
pathological
scenarios.
Language: Английский